Kennedy Capital Management, Inc. Dice Therapeutics, Inc. Transaction History

Kennedy Capital Management, Inc.

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q1 2023 May 15, 2023	BUY	$26.05 - $32.31 $1,615 - $2,003	62 Added 0.1%	62,497 $1.79 Million
Q4 2022 Feb 14, 2023	BUY	$19.77 - $42.23 $1.23 Million - $2.64 Million	62,435 New	62,435 $1.95 Million

17.7K

13K

Ticker DICE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,430,000
Description
DICE Therapeutics, Inc., a biopharmaceutical company, builds various oral therapeutic candidates to treat chronic diseases in immunology and other therapeutic areas. Its platform DELSCAPE, is designed to discover selective oral small molecules to modulate protein-protein interactions (PPIs) as effectively as systemic biologics. The company's lea...

Get notified when there are updates to the investment portfolio of Kennedy Capital Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Kennedy Capital Management, Inc. with notifications on news.